We are live on ! Find out more
IOVA icon

Iovance Biotherapeutics
IOVA

269 hedge funds and large institutions have $6.9B invested in Iovance Biotherapeutics in 2020 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 86 increasing their positions, 97 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more call options, than puts

Call options by funds: $120M | Put options by funds: $77.8M

51% more capital invested

Capital invested by funds: $4.58B → $6.9B (+$2.32B)

46% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 39

22% more funds holding in top 10

Funds holding in top 10: 9 → 11 (+2)

7% more funds holding

Funds holding: 252 → 269 (+17)

5.83% more ownership

Funds ownership: 95.58% → 101.41% (+5.8%)

11% less repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 97

Holders
269
Holders Change
+17
Holders Change %
+6.75%
% of All Funds
4.76%
Holding in Top 10
11
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+22.22%
% of All Funds
0.19%
New
57
Increased
86
Reduced
97
Closed
39
Calls
$120M
Puts
$77.8M
Net Calls
+$42M
Net Calls Change
+$15.8M

Top Buyers

1
AIM
ARK Investment Management
Florida
+$294M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$197M
3
CCM
Consonance Capital Management
New York
+$67.9M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$53.1M
5
NAMA
Nikko Asset Management Americas
New York
+$35.9M

Top Sellers

1
GPP
Great Point Partners
Connecticut
-$117M
2
ACA
Avoro Capital Advisors
New York
-$80.8M
3
PA
Perceptive Advisors
New York
-$36.5M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$29.4M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$27.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jennison Associates
51
Jennison Associates
New York
$15.6M -$377K -9,496 -3%
California Public Employees Retirement System
52
California Public Employees Retirement System
California
$15.5M +$787K +19,823 +6%
RPAM
53
Rhenman & Partners Asset Management
Sweden
$14.8M -$794K -20,000 -6%
SEI Investments
54
SEI Investments
Pennsylvania
$14.8M -$867K -21,847 -6%
UBS AM
55
UBS AM
Illinois
$14.4M +$815K +20,531 +7%
Two Sigma Investments
56
Two Sigma Investments
New York
$14.3M +$11.8M +296,426 +2,761%
TCM
57
Tekla Capital Management
Massachusetts
$12.6M – – –
PCM
58
Peregrine Capital Management
Minnesota
$12.5M -$4.04M -101,839 -27%
Swiss National Bank
59
Swiss National Bank
Switzerland
$11.5M +$179K +4,500 +2%
California State Teachers Retirement System (CalSTRS)
60
California State Teachers Retirement System (CalSTRS)
California
$11.5M +$203K +5,124 +2%
TD Asset Management
61
TD Asset Management
Ontario, Canada
$9.1M +$946K +23,827 +14%
Morgan Stanley
62
Morgan Stanley
New York
$8.8M +$3.23M +81,368 +75%
Millennium Management
63
Millennium Management
New York
$8.23M -$25.2M -634,217 -78%
BIA
64
Biondo Investment Advisors
Pennsylvania
$8.04M -$349K -8,790 -5%
State Board of Administration of Florida Retirement System
65
State Board of Administration of Florida Retirement System
Florida
$7.73M +$32.3K +813 +0.5%
PC
66
Pier Capital
Connecticut
$7.68M -$2.46M -62,057 -27%
ACP
67
Acuta Capital Partners
California
$7.65M -$5.96M -150,200 -48%
WCM Investment Management
68
WCM Investment Management
California
$7.2M -$2.28M -57,327 -27%
RhumbLine Advisers
69
RhumbLine Advisers
Massachusetts
$6.74M -$49.6K -1,249 -0.9%
Allianz Asset Management
70
Allianz Asset Management
Germany
$6.51M -$71.8K -1,808 -1%
Dimensional Fund Advisors
71
Dimensional Fund Advisors
Texas
$6.44M +$1.62M +40,816 +42%
OCM
72
Osterweis Capital Management
California
$6.4M -$785K -19,770 -13%
D.E. Shaw & Co
73
D.E. Shaw & Co
New York
$5.98M +$3.27M +82,391 +178%
SFM
74
Sphera Funds Management
Israel
$5.91M -$4.99M -125,711 -50%
PPA
75
Parametric Portfolio Associates
Washington
$5.87M +$613K +15,451 +14%
1 2
3
4 5

IOVA Hedge Fund Activity: Q4 2020 in Review

269 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Iovance Biotherapeutics (IOVA) for Q4 2020, worth a combined $6.9B — up 51% from $4.58B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new IOVA positions and 39 closed out — a net gain of 18 holders — while 86 added to existing stakes and 97 trimmed.

The largest buyer was ARK Investment Management, adding an estimated $294M. The largest seller was Great Point Partners, cutting an estimated $117M.

  • 269 institutional investors held Iovance Biotherapeutics (IOVA) as of Q4 2020, up from 252 in Q3 2020.
  • Funds reported $6.9B of Iovance Biotherapeutics stock for Q4 2020, up 51% quarter-over-quarter.
  • 57 funds opened new Iovance Biotherapeutics positions in Q4 2020 and 39 closed out, a net change of +18 holders.
  • The largest Iovance Biotherapeutics buyer in Q4 2020 was ARK Investment Management, an estimated $294M added.
  • The largest Iovance Biotherapeutics seller in Q4 2020 was Great Point Partners, an estimated $117M sold.

Based on aggregated 13F filings for Q4 2020.